Aspirin/Caffeine/Dihydrocodeine Tartrate

阿司匹林/咖啡因/酒石酸双氢可待因

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAspirin/Caffeine/Dihydrocodeine Tartrate
Drug Alias NameSynalgos-Dc
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsAdenosine A1 receptor antagonistsOpioid receptors agonists +[4] 
TargetsOpioid receptorsAdenosine A1 receptorAdenosine A2a receptor +[4] 
Therapy Area/IndicationsPain
Global Approved IndicationsPain
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1958/07/07
Country/TerritoryUnited States
CombinationsYes CaffeineDihydrocodeine TartrateAspirin
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesSun Pharmaceutical Industries Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSun Pharmaceutical Industries Ltd
Active IndicationsN/A
Inactive IndicationsPain

Other Information

ATC CodeN/A
Related LinksN/A